(Q70399223)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7094977%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7094977%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

1 reference

B Breithaupt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7094977%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

M Tittel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7094977%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

publication date

1 January 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7094977%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

10 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7094977%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7094977%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7094977%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

77-84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7094977%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00606429

10 October 2019

exact match

0 references

cites work

Allopurinol hypersensitivity.

1 reference

12 December 2020

Action of benzbromarone on the renal excretion of allantoin in normouricemic and hyperuricemic humans (author's transl)

1 reference

12 December 2020

Determination of allopurinol and oxipurinol in biological fluids by high-performance liquid chromatography

1 reference

12 December 2020

Urinary excretion of purines, pyrimidines and pyrazolopyrimidines in patients treated with allopurinol or oxipurinol

1 reference

12 December 2020

The allopurinol hypersensitivity syndrome

1 reference

12 December 2020

High-performance liquid chromatographic assay for allopurinol and oxipurinol in human plasma

1 reference

12 December 2020

Time course of oxipurinol levels in plasma following single dose and chronic administration of allopurinol in different pharmaceutical preparations (author's transl)

1 reference

12 December 2020

Renal clearance of oxipurinol, the chief metabolite of allopurinol

1 reference

12 December 2020

An enzymatic basis for variation in response to allopurinol. Hypoxanthine-guanine phosphoribosyltransferase deficiency

1 reference

12 December 2020

Allopurinol sensitivity: report of two cases

1 reference

12 December 2020

High pressure liquid chromatographic determination of allopurinol and oxipurinol in serum

1 reference

12 December 2020

Clinical evaluation of benzbromarone. A new uricosuric drug

1 reference

12 December 2020

4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS

1 reference

12 December 2020

THE ENZYMOLOGY OF FEEDBACK INHIBITION OF GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE BY PURINE RIBONUCLEOTIDES.

1 reference

12 December 2020

The pharmacology of hypouricemic effect of benzbromarone

1 reference

12 December 2020

Allopurinol and gouty hyperuricemia. Efficacy of a single daily dose.

1 reference

12 December 2020

1 reference

12 December 2020

Metabolic studies of allopurinol, an inhibitor of xanthine oxidase

1 reference

12 December 2020

Allopurinol and thiazides.

1 reference

12 December 2020

Effects of allopurinol in relation to purine biosynthesis

1 reference

12 December 2020

THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT

1 reference

12 December 2020

The determination of allopurinol and oxipurinol in human plasma and urine

1 reference

12 December 2020

EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT

1 reference

12 December 2020

Ribonucleosides of allopurinol and oxoallopurinol. Isolation from human urine, enzymatic synthesis, and characterization

1 reference

12 December 2020

Stoichiometric Inhibition of Reduced Xanthine Oxidase by Hydroxypyrazolo[3,4-d]pyrimidines

1 reference

12 December 2020

Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromise

1 reference

12 December 2020

Nature of the uricosuric action of benziodarone

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00606429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7094977%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference